679 related articles for article (PubMed ID: 25837307)
1. Antithrombin heparin binding site deficiency: A challenging diagnosis of a not so benign thrombophilia.
Orlando C; Heylen O; Lissens W; Jochmans K
Thromb Res; 2015 Jun; 135(6):1179-85. PubMed ID: 25837307
[TBL] [Abstract][Full Text] [Related]
2. Impact of the type of SERPINC1 mutation and subtype of antithrombin deficiency on the thrombotic phenotype in hereditary antithrombin deficiency.
Luxembourg B; Pavlova A; Geisen C; Spannagl M; Bergmann F; Krause M; Alesci S; Seifried E; Lindhoff-Last E
Thromb Haemost; 2014 Feb; 111(2):249-57. PubMed ID: 24196373
[TBL] [Abstract][Full Text] [Related]
3. Development of a novel, rapid assay for detection of heparin-binding defect antithrombin deficiencies: the heparin-antithrombin binding (HAB) ratio.
Moore GW; de Jager N; Cutler JA
Thromb Res; 2015 Jan; 135(1):161-6. PubMed ID: 25466846
[TBL] [Abstract][Full Text] [Related]
4. Progressive chromogenic anti-factor Xa assay and its use in the classification of antithrombin deficiencies.
Kovács B; Bereczky Z; Selmeczi A; Gindele R; Oláh Z; Kerényi A; Boda Z; Muszbek L
Clin Chem Lab Med; 2014 Dec; 52(12):1797-806. PubMed ID: 24968404
[TBL] [Abstract][Full Text] [Related]
5. [Hereditary deficiency of antithrombin III, protein C, protein S and factor XII in 121 patients with venous or arterial thrombosis].
Miljić P; Rolović Z; Elezović I; Antunović P; Stanojević M; Colović M
Srp Arh Celok Lek; 1999; 127(1-2):21-7. PubMed ID: 10377836
[TBL] [Abstract][Full Text] [Related]
6. Genetic Risk Factors in Venous Thromboembolism.
Hotoleanu C
Adv Exp Med Biol; 2017; 906():253-272. PubMed ID: 27638626
[TBL] [Abstract][Full Text] [Related]
7. Founder effect is responsible for the p.Leu131Phe heparin-binding-site antithrombin mutation common in Hungary: phenotype analysis in a large cohort.
Gindele R; Oláh Z; Ilonczai P; Speker M; Udvari Á; Selmeczi A; Pfliegler G; Marján E; Kovács B; Boda Z; Muszbek L; Bereczky Z
J Thromb Haemost; 2016 Apr; 14(4):704-15. PubMed ID: 26748602
[TBL] [Abstract][Full Text] [Related]
8. Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis?
Linnemann B; Schindewolf M; Zgouras D; Erbe M; Jarosch-Preusche M; Lindhoff-Last E
Thromb Res; 2008; 121(6):743-50. PubMed ID: 17804043
[TBL] [Abstract][Full Text] [Related]
9. Age-specific onset and distribution of the natural anticoagulant deficiency in pediatric thromboembolism.
Ichiyama M; Ohga S; Ochiai M; Tanaka K; Matsunaga Y; Kusuda T; Inoue H; Ishimura M; Takimoto T; Koga Y; Hotta T; Kang D; Hara T
Pediatr Res; 2016 Jan; 79(1-1):81-6. PubMed ID: 26372516
[TBL] [Abstract][Full Text] [Related]
10. Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families.
Martinelli I; Mannucci PM; De Stefano V; Taioli E; Rossi V; Crosti F; Paciaroni K; Leone G; Faioni EM
Blood; 1998 Oct; 92(7):2353-8. PubMed ID: 9746774
[TBL] [Abstract][Full Text] [Related]
11. Thrombophilia in childhood: to test or not to test.
Heleen van Ommen C; Middeldorp S
Semin Thromb Hemost; 2011 Oct; 37(7):794-801. PubMed ID: 22187402
[TBL] [Abstract][Full Text] [Related]
12. Inherited antithrombin deficiency: a review.
Patnaik MM; Moll S
Haemophilia; 2008 Nov; 14(6):1229-39. PubMed ID: 19141163
[TBL] [Abstract][Full Text] [Related]
13. Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency.
van Boven HH; Reitsma PH; Rosendaal FR; Bayston TA; Chowdhury V; Bauer KA; Scharrer I; Conard J; Lane DA
Thromb Haemost; 1996 Mar; 75(3):417-21. PubMed ID: 8701400
[TBL] [Abstract][Full Text] [Related]
14. In families with inherited thrombophilia the risk of venous thromboembolism is dependent on the clinical phenotype of the proband.
Rossi E; Ciminello A; Za T; Betti S; Leone G; De Stefano V
Thromb Haemost; 2011 Oct; 106(4):646-54. PubMed ID: 21833444
[TBL] [Abstract][Full Text] [Related]
15. Circulating microparticles and the risk of thrombosis in inherited deficiencies of antithrombin, protein C and protein S.
Campello E; Spiezia L; Radu CM; Bulato C; Gavasso S; Tormene D; Woodhams B; Dalla Valle F; Simioni P
Thromb Haemost; 2016 Jan; 115(1):81-8. PubMed ID: 26354831
[TBL] [Abstract][Full Text] [Related]
16. Puzzling questions on antithrombin: Diagnostic limitations and real incidence in venous and arterial thrombosis.
Corral J; Vicente V
Thromb Res; 2015 Jun; 135(6):1047-8. PubMed ID: 25910517
[No Abstract] [Full Text] [Related]
17. Report of a novel kindred with antithrombin heparin-binding site variant (47 Arg to His): demand for an automated progressive antithrombin assay to detect molecular variants with low thrombotic risk.
Rossi E; Chiusolo P; Za T; Marietti S; Ciminello A; Leone G; De Stefano V
Thromb Haemost; 2007 Sep; 98(3):695-7. PubMed ID: 17849067
[No Abstract] [Full Text] [Related]
18. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of factor V Leiden mutation and other hereditary thrombophilic factors in Egyptian children with portal vein thrombosis: results of a single-center case-control study.
El-Karaksy H; El-Koofy N; El-Hawary M; Mostafa A; Aziz M; El-Shabrawi M; Mohsen NA; Kotb M; El-Raziky M; El-Sonoon MA; A-Kader H
Ann Hematol; 2004 Nov; 83(11):712-5. PubMed ID: 15309526
[TBL] [Abstract][Full Text] [Related]
20. Type and location of venous thromboembolism in carriers of Factor V Leiden or prothrombin G20210A mutation versus patients with no mutation.
Kovac M; Mitic G; Mikovic Z; Antonijevic N; Djordjevic V; Mikovic D; Mandic V; Rakicevic L; Radojkovic D
Clin Appl Thromb Hemost; 2010 Feb; 16(1):66-70. PubMed ID: 18796457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
